Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 501–600 of 971
Entwicklung von Inhibitoren der Tau‐Aggregation bei Morbus Alzheimer
Bulic, B., Pickhardt, M., Schmidt, B., Mandelkow, E., Waldmann, H., & Mandelkow�, E. (2009) · Angewandte Chemie · doi:10.1002/ange.200802621 · Cited by 26
Peruzzi, P. P., Lawler, S. E., Senior, S. L., Dmitrieva, N., Edser, P. A. H., Gianni, D., Chiocca, E. A., & Wade‐Martins, R. (2009) · Molecular Therapy · doi:10.1038/mt.2009.64 · Cited by 26
Li, S., Li, W., Wu, X., Li, J., Yang, J., Tu, C., Ye, X., & Ling, S. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.03.006 · Cited by 26
Kim, J. Y., Lee, H. K., Jang, J. Y., Yoo, J. K., & Seong, Y. H. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3443 · Cited by 26
Jong, Y.-J. I., Ford, S. R., Seehra, K., Malave, V. B., & Baenziger, N. L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1147fje · Cited by 26
Schork, N. J., Elman, J. A., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230548 · Cited by 25
Current strategies for the treatment of Alzheimer’s disease and other tauopathies
Dickey, C. A., & Petrucelli, L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.5.665 · Cited by 25
Recent Understanding of the Molecular Mechanisms of Alzheimer?s Disease
Grimm, M. O. W., & Hartmann, T. (2011) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s5-004 · Cited by 25
Mira, H., Vilar, M., Esteve, V., Martinell, M., Kogan, M. J., Giralt, E., Salom, D., Mingarro, I., Peñarrubia, L., & Pérez‐Payá, E. (2004) · BMC Structural Biology · doi:10.1186/1472-6807-4-7 · Cited by 25
Ghosal, K., Fan, Q., Dawson, H. N., & Pimplikar, S. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159435 · Cited by 25
Self-citationDeath or secretion? The demise of a plausible assumption about CSF-tau in Alzheimer Disease?
Hall, G. F., & Saman, S. (2012) · Communicative & Integrative Biology · doi:10.4161/cib.21437 · Cited by 24
The neuropathology of Alzheimer's disease in the year 2005
Masters, C. L., & Beyreuther, K. T. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.030 · Cited by 24
Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer’s Disease
Kaeser, G. E., & Chun, J. J. M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00390 · Cited by 24
Mechanism-based treatments for Alzheimer's disease
Davies, P., & Koppel, J. L. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/pdavies · Cited by 24
New Age of Neuroproteomics in Alzheimer’s Disease Research
Kováčech, B., Žilka, N., & Novák, M. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9358-6 · Cited by 24
Croft, C. L., Kurbatskaya, K., Hanger, D. P., & Noble, W. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-07906-1 · Cited by 24
Suh, E. C., Jung, Y. J., Kim, Y. A., Park, E.-M., Lee, S. J., & Lee, K. E. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.007 · Cited by 24
Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys
Tu, Z., Yan, S., Han, B., Li, C., Liang, W., Lin, Y., Ding, Y., Wei, H., Wang, L., Xu, H., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01601-6 · Cited by 23
Afreen, S., Methner, D. N. R., & Ferreira, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.026 · Cited by 23
Self-citationTherapeutic Effects of Curcumin on Alzheimer’s Disease
Yao, E. C., & Xue, L. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.34014 · Cited by 23
An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
Marcelli, S., Ficulle, E., Piccolo, L., Corbo, M., & Feligioni, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.023 · Cited by 23
Role of WWOX WOX1 in Alzheimer s disease pathology and in cell death signaling
Teng, C.-C., Yang, Y.-T., Chen, Y.-C., Kuo, Y.-M., & Sze, C.-I. (2013) · Frontiers in Bioscience-Scholar · doi:10.2741/s358 · Cited by 22
Testa, G., Giannelli, S., Sottero, B., Staurenghi, E., Giaccone, G., Caroppo, P., Gamba, P., & Leonarduzzi, G. (2023) · Antioxidants · doi:10.3390/antiox12030631 · Cited by 22
Bignante, E. A., Ponce, N. E., Heredia, F., Musso, J., Krawczyk, M. C., Millan, J., Pigino, G. F., Inestrosa, N. C., Boccia, M. M., & Lorenzo, A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.013 · Cited by 22
Indirubin-3′-monoxime inhibits β-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells
Zhang, S., Zhang, Y., Xu, L., Lin, X., Lu, J., Di, Q., Shi, J., & Xu, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.030 · Cited by 22
Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer’s Disease
Moosavi, B., Mousavi, B., & Macreadie, I. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150173 · Cited by 22
Johansson, S. M., Radesäter, A., Cowburn, R. F., Thyberg, J., & Luthman, J. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0069-z · Cited by 22
Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer’s disease
Liu, J., Li, X., & Qu, J. (2023) · Neuroreport · doi:10.1097/wnr.0000000000001952 · Cited by 22
Martínez‐Mármol, R., Small, C., Jiang, A., Palliyaguru, T., Wallis, T. P., Gormal, R. S., Sibarita, J., Götz, J., & Meunier, F. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01825-y · Cited by 22
Novel ventriculoperitoneal shunt in Alzheimer´s disease cerebrospinal fluid biomarkers
Silverberg, G. D., Mayo, M. R., Saul, T., Carvalho, J., & McGuire, D. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.1.97 · Cited by 22
The Role of the Carboxyl-Terminal Sequence of Tau and MAP2 in the Pathogenesis of Dementia
Xie, C., & Miyasaka, T. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00158 · Cited by 22
Aggregation of Aβ(1–42) in the presence of short peptides: conformational studies
Laczkó, I., Vass, E., Soós, K., Fülöp, L., Zarándi, M., & Penke, B. (2008) · Journal of Peptide Science · doi:10.1002/psc.990 · Cited by 22
Perturbed Calcineurin-NFAT Signaling Is Associated with the Development of Alzheimer’s Disease
Asai, M., Kinjo, A., Kimura, S., Mori, R., Kawakubo, T., Shirotani, K., Yagishita, S., Maruyama, K., & Iwata, N. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00350 · Cited by 22
Li, G., Liu, F., Cui, X., Li, J., & Xu, Y. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1162-4 · Cited by 22
Acetylsalicylic acid decreases tau phosphorylation at serine 422
Tortosa, E., Ávila, J., & Pérez, M. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.066 · Cited by 21
Alzheimer's disease models and functional genomics—How many needles are there in the haystack?
Götz, J., Matamales, M., Götz, N. N., Ittner, L. M., & Eckert, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00320 · Cited by 21
Lajarín-Cuesta, R., Arribas, R. L., Nanclares, C., García‐Frutos, E. M., Gandía, L., & Ríos, C. D. L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.030 · Cited by 21
Moosecker, S., Gomes, P., Dioli, C., Yu, S., Sotiropoulos, I., & Almeida, O. F. X. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00239 · Cited by 20
Plexin-A4 mediates amyloid-β–induced tau pathology in Alzheimer’s disease animal model
Chung, S., Yang, J., Kim, H. J., Hwang, E. M., Lee, W., Suh, K. Y., Choi, H., & Mook‐Jung, I. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102075 · Cited by 20
Wu, D., Yu, N., Gao, Y., Xiong, R., Liu, L., Lei, H., Jin, S., Liu, J., Liu, Y., Xie, J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00614-7 · Cited by 20
Wheeler, H. B., Madrigal, A. A., & Chaim, I. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317860121 · Cited by 20
Bobba, A., Amadoro, G., Petragallo, V. A., Calissano, P., & Atlante, A. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.04.001 · Cited by 20
Tsai, Y.-C., Lee, Y., Lam, K., Lin, J., Wang, J., Yen, M., & Cheng, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069320 · Cited by 20
Deletion of tau attenuates heat shock‐induced injury in cultured cortical neurons
Miao, Y., Chen, J., Zhang, Q., & Sun, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22188 · Cited by 19
Ng, B., Rowland, H. A., Wei, L., Arunasalam, K., Hayes, E. M., Koychev, I. G., Hedegaard, A., Ribé, E. M., Chan, D., Chessell, T., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac267 · Cited by 19
Immunotherapy for Alzheimer's disease
Wang, W., Fan, L., Xu, D.-E., Wen, Z., Yu, R., & Ma, Q. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms065 · Cited by 19
Can tau filaments be both physiologically beneficial and toxic?
King, M. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.019 · Cited by 19
Liu, X., Yue, C., Xu, Z., Shu, H., Pu, M., Yu, H., Shi, Y., Zhuang, L., Xu, X., & Zhang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041198 · Cited by 19
Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau
Zampar, S., & Wirths, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105191 · Cited by 18
Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice
Vargas-Caballero, M., Denk, F., Wobst, H. J., Arch, E., Pegasiou, C.-M., Oliver, P. L., Shipton, O. A., Paulsen, O., & Wade-Martins, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00201 · Cited by 18
“There is mounting evidence for tau as a downstreammediator of Aβ effects (Rapoport et al., 2002; Roberson et al., 2007, 2011; Shipton et al., 2011; Vossel et al., 2011), however, the mechanisms Frontiers in Neuroscience | www.frontiersin.org 5 April 2017 | Volume 11 | Article 201 FIGURE 3 | Tau…”
BackgroundWhite matter damage in Alzheimer’s disease: contribution of oligodendrocytes
Zhou, J., Zhang, P., Zhang, B., & Kong, Y. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221021115321 · Cited by 18
“In vitro experiments have shown that tau deletion prevents Aβ-induced neuronal cell death, while reexpression of the knocked-out tau gene in neuronal cells restores Aβ-induced neurotoxicity [39].”
BackgroundResultOvercoming barriers and thresholds – signaling of oligomeric Aβ through the prion protein to Fyn
Wang, H., Ren, C. H., Gunawardana, C. G., & Schmitt-Ulms, G. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-24 · Cited by 18
Borreca, A., Latina, V., Corsetti, V., Middei, S., Piccinin, S., Valle, F. D., Bussani, R., Ammassari‐Teule, M., Nisticò, R., Calissano, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0974-3 · Cited by 18
Paudel, B., Jeong, S., Peña-Martinez, C., Rickman, A. D., Haluck-Kangas, A., Bartom, E. T., Fredriksen, K., Affaneh, A., Kessler, J. A., Mazzulli, J. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44465-8 · Cited by 18
Self-citationAlzheimer's disease and related dementias
Hardy, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.003 · Cited by 18
The Role of Immunity in Alzheimer's Disease
McManus, R. M. (2022) · Advanced Biology · doi:10.1002/adbi.202101166 · Cited by 18
Systems medicine and the integration of bioinformatic tools for the diagnosis of alzheimer's disease
Orešič, M., Lötjönen, J. M. P., & Soininen, H. S. (2010) · Genome Medicine · doi:10.1186/gm204 · Cited by 18
Luo, J. J., Wallace, W., & Kusiak, J. W. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120294 · Cited by 17
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Chen, J., Xu, S., Wang, L., Liu, X., Liu, G., Tan, Q., Li, W., Zhang, S., & Du, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.033 · Cited by 17
Guo, P., Zeng, M., Cao, B., Liu, M., Zhang, Y., Jia, J., Zhang, Q., Zhang, B., Wang, R., Xiong, W., et al. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105214 · Cited by 17
The Aβcentric Pathway of Alzheimer’s Disease
Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R. A., Opazo, C., Novakovic, K. E., Rowe, C. C., & Masters, C. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_2 · Cited by 17
Maltsev, A. V., Santockyte, R., Bystryak, S. M., & Galzitskaya, O. V. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131562 · Cited by 17
Omar, S. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00004-5 · Cited by 17
Sui, H., Zhang, L., Liu, Z., & Jin, Y. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.161 · Cited by 17
Alzheimer's disease: is a vaccine possible?
Alves, R. P. D. S., Yang, M., Batista, M. T., & Ferreira, L. C. D. S. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143434 · Cited by 17
Yook, Y., Lee, K. Y., Kim, E. Y., Lizarazo, S., Yu, X., & Tsai, N. (2024) · EMBO Reports · doi:10.1038/s44319-024-00090-0 · Cited by 17
Zhu, X., Ma, T., Liu, L., & Dai, W.-Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332160 · Cited by 16
Aβ Toxicity in Primary Cultured Neurons
Ferreira, A., Sinjoanu, R. C., Nicholson, A. M., & Kleinschmidt, S. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0_11 · Cited by 16
Self-citationModeling tauopathy: a range of complementary approaches
Hall, G. F., & Yao, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.002 · Cited by 16
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
Robbins, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373670 · Cited by 16
Animal models for prion-like diseases
Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 16
Model scenarios for cell cycle re-entry in Alzheimer's disease
Pandey, N., & Vinod, P. K. U. (2022) · iScience · doi:10.1016/j.isci.2022.104543 · Cited by 16
Relationship between the tau protein and choroid plexus volume in Alzheimer’s disease
Ota, M., Sato, N., Nakaya, M., Shigemoto, Y., Kimura, Y., Chiba, E., Yokoi, Y., Tsukamoto, T., & Matsuda, H. (2023) · Neuroreport · doi:10.1097/wnr.0000000000001923 · Cited by 16
Xu, J., Zhang, R., Zuo, P., Yang, N., Ji, C., Liu, W., Wang, Y., Wang, H., Wu, A., Yue, Y., et al. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9860-0 · Cited by 16
Pan, R., Initiative, A. D. N., Luo, S., Huang, Q., Li, W., Cai, T., Lai, K., & Shi, X. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220002 · Cited by 15
Kopeć, K., Koziorowski, D., & Szlufik, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157552 · Cited by 15
Campos‐Peña, V., Tapia-Ramírez, J., Sánchez‐Torres, C., & Meraz‐Ríos, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1198 · Cited by 15
The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity
Cisternas, P., Taylor, X., Martínez, P., Maldonado, O., Jury, N., & Lasagna‐Reeves, C. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac235 · Cited by 15
Dassie, E., Andrews, M. R., Bensadoun, J., Cacquevel, M., Schneider, B. L., Aebischer, P., Wouters, F. S., Richardson, J. C., Hussain, I., Howlett, D. R., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.011 · Cited by 15
Roth, J. R., Rush, T., Thompson, S. J., Aldaher, A. R., Dunn, T. B., Mesina, J. S., Cochran, J. N., Boyle, N. R., Dean, H. B., Yang, Z. W., et al. (2023) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.001 · Cited by 15
Gene Knockout of tau Expression Does Not Contribute to the Pathogenesis of Prion Disease
Lawson, V., Klemm, H. M. J., Welton, J. M., Masters, C. L., Crouch, P. J., Cappai, R., & Ciccotosto, G. D. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318235b471 · Cited by 15
Bang, Y., Lim, J., Kim, S. S., Jeong, H. M., Jung, K., Kang, I.-H., Lee, K.-Y., & Choi, H. J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.04.006 · Cited by 15
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Kayed, R., Castillo-Carranza, D., & Guerrero-Muñoz, M. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s40131 · Cited by 14
Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
Ahn, K.-C., Learman, C. R., Baker, G. B., Weaver, C. L., Chung, P., Kim, H., & Song, M.-S. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e297 · Cited by 14
Microglia energy metabolism: A new perspective on Alzheimer's disease treatment
Wu, Q.-L., Yang, X., Luo, J.-X., Liu, L., Zhou, Y., & Lu, M. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123585 · Cited by 14
Gene-environment interplay in neurogenesis and neurodegeneration
Palomo, T., Archer, T., Beninger, R. J., & Kostrzewa, R. M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033279 · Cited by 14
Bartley, S. C., Proctor, M. T., Xia, H., Ho, E., Kang, D. S., Schuster, K. H., Bicca, M. A., Seckler, H. S., Viola, K. L., Patrie, S. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042208 · Cited by 14
Therapeutic Approaches for the Treatment of Alzheimer's Disease: An Overview
Lau, L., & Brodney, M. A. (2007) · Springer eBooks · doi:10.1007/7355_2007_017 · Cited by 14
Rández‐Gil, F., Bojunga, L., Estruch, F., Winderickx, J., Poeta, M. D., & Prieto, J. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592159 · Cited by 14
In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models
Riban, V., Meunier, J., Buttigieg, D., Villard, V., & Verleye, M. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200601151007 · Cited by 14
Zhang, J., Shu, Y., Qu, Y., Zhang, L., Chu, T., Zheng, Y., & Zhao, H. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0991-0 · Cited by 13
Asparagine endopeptidase cleaves tau and promotes neurodegeneration
Rosenmann, H. (2014) · Nature Medicine · doi:10.1038/nm.3749 · Cited by 13
Benhamron, S., Rozenstein‐Tsalkovich, L., Nitzan, K., Abramsky, O., & Rosenmann, H. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.004 · Cited by 13
Chapter 2 Live‐Cell Imaging in the Study of Neurodegeneration
Bakota, L., & Brandt, R. (2009) · International review of cytology · doi:10.1016/s1937-6448(09)76002-2 · Cited by 13
Modulation of tau pathology in tau transgenic models
Brion, J., Ando, K., Héraud, C., & Leroy, K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380996 · Cited by 13
Amyloid β Hypothesis in the Development of Therapeutic Agents for Alzheimer’s Disease
Adeniji, A. O., Adams, P. W., & Mody, V. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00007-6 · Cited by 13
Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in App NLF Knock-In Mice
Barrett, T., Stangis, K. A., Saito, T., Saido, T. C., & Park, K. H. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210091 · Cited by 13
Wen, X., An, P., Li, H., Zhou, Z., Sun, Y., Wang, J., Ma, L., & Lu, B. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00518-2 · Cited by 13
[Progression of gestational hypertension to preeclampsia].
Romero-Arauz, J. F., Ortiz-Díaz, C. B., Leaños‐Miranda, A., & Martínez-Rodríguez, Ó. A. (2014) · PubMed · Cited by 12
The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
You, G., Yao, J., Liu, Q., & Li, N. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120421 · Cited by 12
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.